ライフサイエンスコーパス: sponsor

1 related to study drug by the investigator or sponsor.

2 treatment related by either investigators or sponsor.

3 schedule that was computer generated by the sponsor.

4 irect electronic query of trial contacts and sponsors.

5 Accrual information was obtained from trial sponsors.

6 The National Cancer Institute sponsored a clinical trials planning meeting in 2012 to

7 The American Thoracic Society (ATS) sponsored a committee of international experts to examin

8 nstitute; and Merck Childhood Asthma Network sponsored a joint workshop to discuss the current state

9 iseases, National Institutes of Health (NIH) sponsored a series of meetings to foster progress toward

10 LD, the American College of Cardiology (ACC) sponsored a stakeholders meeting on October 1 to 2, 2015

11 , 2013, the American Journal of Epidemiology sponsored a symposium at the Society for Epidemiologic R

12 f Health Blueprint for Neuroscience Research sponsored a workshop in 2009.

13 Institute of Allergy and Infectious Diseases sponsored a workshop on drug allergy.

14 Institute of Allergy and Infectious Diseases sponsored a workshop that provided a venue for in-depth

15 e, randomized, National Institutes of Health-sponsored Action to Control Cardiovascular Risk in Diabe

16 ctive, analysis was conducted of data from 9 sponsor-administered, randomized, open-label trials.

17 The patients were recruited through the NIMH-sponsored Advanced Center for Interventions and Services

18 due to security concerns raised by NASA, the sponsoring agency.

19 ndustry relationships via diversification of sponsors, agents, and therapeutic areas.

20 recommended termination of the trial and the sponsor agreed.

21 Association for the Study of Liver Diseases sponsored an endpoints conference to help accelerate the

22 e Agency for Healthcare Research and Quality sponsored an international group of experts in patient s

23 Study teams from the sponsor and clinical research organisation, investigator

24 The sponsor and the steering committee terminated the trial

25 Sponsors and investigators must accept responsibility fo

26 ng measures were inconsistently used by both sponsors and the U.S. EPA.

27 eractions among regulatory agencies, payers, sponsors, and investigators and proposes collaboration a

28 Clinicians, sponsors, and investigators are encouraged to work with

29 es that include the large number of industry-sponsored antidepressant trials distort the picture of a

30 ites when U.S. National Institutes of Health-sponsored articles (treatment) become freely available f

31 The benefits and risks of the industry-sponsored AS-DCAT from the perspectives of the sponsorin

32 he National Heart, Lung, and Blood Institute-sponsored Asthma Clinical Research Network and AsthmaNet

33 In the US, the ongoing NIH-sponsored ATTRACT trial should clarify the risk-benefit

34 d Other Supplier Public Use File and the CMS-sponsored August through December 2013 Open Payments pro

35 The ongoing National Institutes of Health-sponsored Best Endovascular Versus Best Surgical Therapy

36 y organization, supports research in part by sponsoring biennial research symposia on these disorders

37 e of Allergy and Infectious Diseases (NIAID)-sponsored Bioinformatics Resource Center dedicated to pr

38 al patient-level data from completed studies sponsored by 13 pharmaceutical companies.

39 anff, Alberta, Canada, on February 11-16 and sponsored by Astellas Pharma and Regulus Therapeutics.

40 one of the first independent CE analyses not sponsored by either Novartis or Amgen, the makers of ZA

41 This clinical study (BAT117213 study) is sponsored by GlaxoSmithKline (GSK) with associated explo

42 (-1.99; 95% CI -2.68, -1.31) versus studies sponsored by industry (-0.73; 95% CI -1.00, -0.47) (p va

43 data from 11 eligible of 17 provided trials sponsored by Medtronic (Minneapolis, Minnesota) (n = 130

44 king, as well as diet and physical activity, sponsored by multiple community organizations, including

45 Sponsored by New England Biolabs, the Cayman Chemical Co

46 statins was significantly larger for studies sponsored by nonindustry sources (-1.99; 95% CI -2.68, -

47 Trials were for off-label uses of gabapentin sponsored by Pfizer and Parke-Davis, and documents were

48 detailed comparisons of two drugs in studies sponsored by pharmaceutical companies.

49 The NOS is the premier event sponsored by the ACS Division of Organic Chemistry (ORGN

50 Antimicrobial-Resistant Organisms (AROs) was sponsored by the Alberta Ministry of Health to provide e

51 were the focus of a 2-day research symposium sponsored by the American Association for the Study of L

52 (D2B) Alliance, a national quality campaign sponsored by the American College of Cardiology and 38 p

53 e, a hospital-based cancer registry database sponsored by the American College of Surgeons and the Am

54 itled "Diabetes and the Microbiome," jointly sponsored by the American Diabetes Association and JDRF.

55 A multidisciplinary working group sponsored by the Canadian and US government DRI steering

56 andated and publicly reported quality metric sponsored by the Centers for Medicare and Medicaid Servi

57 er 5 and 6, 2013 in Silver Spring, Maryland, sponsored by the FDA and the American Association for th

58 he 2003 National Survey of Children's Health sponsored by the federal Maternal and Child Health Burea

59 hat participate in the Mini-Sentinel program sponsored by the Food and Drug Administration.

60 me; Bronchial Obstruction and Asthma Cohort; sponsored by the French National Institute of Health and

61 Workshops sponsored by the Institute of Medicine (IOM) and the Wor

62 n system for peripheral lung adenocarcinomas sponsored by the International Association for the Study

63 are the result of this collaborative project sponsored by the MDS Foundation.

64 Concurrently with a workshop sponsored by the National Cancer Institute, we identifie

65 in the Visual System," held in October 2015 sponsored by the National Eye Institute as part of their

66 hy Clinical Research Network (DRCR Network), sponsored by the National Eye Institute, reported the re

67 olled trials (ARMA trial and ALVEOLI trial), sponsored by the National Heart, Lung, and Blood Institu

68 Cardiovascular Cell Therapy Research Network sponsored by the National Heart, Lung, and Blood Institu

69 Cardiovascular RCTs sponsored by the National Heart, Lung, and Blood Institu

70 al consultation on bacterial vaginosis (BV), sponsored by the National Institute of Allergy and Infec

71 A workshop sponsored by the National Institute of Diabetes and Dige

72 The goals of this workshop sponsored by the National Institute of Diabetes and Dige

73 A single-day workshop sponsored by the National Institute of Diabetes and Dige

74 g Palliative Care in the ICU Project website sponsored by the National Institutes of Health and the C

75 international meeting on male breast cancer, sponsored by the National Institutes of Health Office of

76 ntermediate Outcome Measures in COPD Study), sponsored by the National Institutes of Health, has esta

77 mmary of the work accomplished at a workshop sponsored by the NIH to review the existing evidence to

78 al research and what educational initiatives sponsored by the NIH would most likely effect change?

79 We know that clinical trials sponsored by the pharmaceutical industry are likely to e

80 rincipal investigators on US clinical trials sponsored by the pharmaceutical industry.

81 rom this debate: The first will be a meeting sponsored by the Region Languedoc-Roussillon on the deve

82 In December 2014, a workshop sponsored by the subcommittee on collaborative process o

83 A tournament sponsored by the U.S. intelligence community revealed wa

84 t the British Columbia Cancer Agency (BCCA), sponsored by the U.S. National Cancer Institute.

85 : Insights from Plant Viral Infections'' was sponsored by the United States-Israel Binational Agricul

86 It was sponsored by the Universite Laval and the Eunice Kennedy

87 Two meetings, one sponsored by the Wellcome Trust in 2012 and the other by

88 nd Annual Workshop on Cancer Systems Biology sponsored by Tufts University, Boston, Massachusetts, in

89 It is sponsored by University College London (UCL).

90 To examine the extent to which positive NCI-sponsored cancer treatment trials have benefited patient

91 5 National Heart, Lung, and Blood Institute-sponsored Cardiovascular Cell Therapy Research Network (

92 he National Heart, Lung, and Blood Institute-sponsored Cardiovascular Cell Therapy Research Network o

93 ation in National Institutes of Health (NIH)-sponsored cardiovascular randomized controlled trials (R

94 the rate of international enrollment in NIH-sponsored cardiovascular RCTs has not been described.

95 Ps being associated with results of the NIMH sponsored CATIE trial, other SNPs showed weakly positive

96 Industry-sponsored child and adolescent depression trials suffer

97 Industry-sponsored clinical drug studies are associated with publ

98 ipating in the National Institutes of Health-sponsored Clinical Islet Transplantation (CIT) Consortiu

99 ere treated in the Children's Oncology Group sponsored clinical trial, AAML0122.

100 and an appreciable number of public-company-sponsored clinical trials are progressing through phases

101 t will be used to evaluate proposals for NCI-sponsored clinical trials in which omics tests will be u

102 disease-specific, National Cancer Institute-sponsored clinics.

103 om National Heart, Lung, and Blood Institute-sponsored cohorts, we estimated lifetime risks for devel

104 r, National Heart, Lung, and Blood Institute-sponsored cohorts.

105 a National Heart, Lung, and Blood Institute-sponsored collaboration between the U.S. Food and Drug A

106 oncealment of intervention, incomplete data, sponsor company involvement, and other bias), consistenc

107 onsored AS-DCAT from the perspectives of the sponsoring company and participating sites are discussed

108 All sponsor-conducted randomized controlled trials of fluoxe

109 or more of National Cancer Institute (NCI) -sponsored Cooperative Group phase III trials failed to a

110 he valuation of paintings placed next to the sponsoring corporate logo, an effect that correlates wit

111 Sexually active women (n=5,871) in the NCI-sponsored Costa Rica HPV Vaccine Trial's prevaccination

112 t at the time of initial marketing approval, sponsors customarily collect comprehensive safety data f

113 orts are currently being tested in federally sponsored demonstration projects.

114 fetal mesencephalic grafts as part of an NIH-sponsored double-blind sham-controlled trial.

115 ly received industry "information," attended sponsored "education," and acted as distributors for sim

116 The trials were stopped early after the sponsor elected to discontinue the development of bococi

117 The sponsor elected to terminate this study due to a clearly

118 evelopment and implementation of an industry-sponsored electronic antimicrobial stewardship data coll

119 l, National Heart, Lung, and Blood Institute-sponsored epidemiological cohort study.

120 with publication of outcomes that favor the sponsor, even when controlling for potential bias in the

121 likelihood of positive outcomes favoring the sponsored experimental drug (75.5% of industry-funded RC

122 the study was terminated when the sponsor failed to secure ongoing funding; 165 patients w

123 but millions of dependents for whom employer-sponsored family coverage is unaffordable could remain a

124 Data on the effectiveness of employer-sponsored financial incentives for employee weight loss

125 ctive encouragement by FDA to clinical trial sponsors for including PROs in drug development programs

126 strate the impact of their research to their sponsors, funders, and fellow academics.

127 investigators, trial participants, patients, sponsors, funders, research ethics committees or institu

128 ure for interaction among the pharmaceutical sponsor funding a drug or device development program, th

129 faculty member received $33,417 in industry-sponsored funding, with most of this money concentrated

130 reevaluated in Food and Drug Administration-sponsored Gastroenterology Regulatory Endpoints and the

131 Company-sponsored (Genentech or Novartis) studies in DME complet

132 ong investigators and collation of data from sponsor-generated or investigator-initiated clinical tri

133 mg, AMG 334 21 mg, or AMG 334 70 mg using a sponsor-generated randomisation sequence centrally execu

134 ased the perceived acceptability of industry-sponsored gifts.

135 ial of mepolizumab (substudy of a larger GSK sponsored global phase III trial, MEA115575) where subje

136 ultiple metabolic enzymes, including enzymes sponsoring glycolysis (enolase 1, triosephosphate isomer

137 sity-affiliated programs were more likely to sponsor H1-Bs than independent programs (39.6% vs. 24.4%

138 oject results, Donate Life America and other sponsors have provided funding for two additional years.

139 ndardization method proprietary to the trial sponsor) HDM SLIT-tablet (ALK, Horsholm, Denmark) in adu

140 ls with HIV from two very similar government-sponsored healthcare systems that reduced or eliminated

141 he National Heart, Lung, and Blood Institute-sponsored Heart Failure Clinical Research Network.

142 Company-sponsored HIV counselling and voluntary testing with ens

143 misation was computer generated by the study sponsor, implemented by a computerised voice interactive

144 .07 to 0.67; no insurance v employer-/school-sponsored insurance) or quit working directly after diag

145 rganization, $5492 among those with employer-sponsored insurance, $5670 among those with Medigap insu

146 3 Eastern Cooperative Oncology Group (ECOG)-sponsored intergroup study.

147 Prospective, single-arm, investigator-sponsored interventional clinical trial.

148 s as the likely intermediary substrates that sponsored inversion formation.

149 nts; allocation was concealed from the study sponsor, investigators, and parents and guardians.

150 The sponsor, investigators, site staff, and patients were ma

151 The study sponsor, investigators, staff, and patients were masked

152 Sponsor, investigators, study monitors, patients, and la

153 This results in dissatisfaction among sponsors, investigators, and staff and restricts the ava

154 of the displayed art or the proximity of the sponsoring logo to the piece of art.

155 he trial was terminated prematurely when the sponsor lost financing.

156 les of Good Publication Practice for Company-Sponsored Medical Research, Data Sharing, Studies That S

157 e 3 National Heart, Lung and Blood Institute-sponsored Multicenter Study of Hydroxyurea trial proved

158 A National Cancer Institute (NCI) sponsored, multicenter, phase 3, randomized clinical tri

159 Pharmaceutical companies and other trial sponsors must submit certain trial results to ClinicalTr

160 Because federally sponsored national health care organizations in the Unit

161 is paper uses a National Academy of Sciences-sponsored ND dataset comprising 905 injurious and proper

162 estigation used study data from SWOG, an NCI-sponsored network cooperative research group.

163 rs, such as within the Department of Defense-sponsored Neurofibromatosis Clinical Trials Consortium.

164 t 14 centers over 21 months within the NINDS-sponsored NeuroNEXT (National Network for Excellence in

165 there is something different about industry-sponsored non-human animal research, perhaps reflecting

166 d by government, universities, philanthropic sponsors of research, major industry players, and collab

167 per patient treated per year, are prominent sponsors of symposia and publications that have advanced

168 present study, the authors obtained from the sponsors of the 10 trials individual patient data, inclu

169 he request of the US and Canadian government sponsors of the ongoing review of the 1997 vitamin D and

170 Developers and sponsors of these candidate products were strongly encou

171 ibute to the publication of research results sponsored or supported by pharmaceutical, medical device

172 was observed for members with FCOIs with the sponsor (OR, 1.79; 95% CI, 0.97-1.46; P = .19 and OR, 3.

173 will be available for external review by the sponsoring organization and any other interested individ

174 will be available for external review by the sponsoring organization and any other interested individ

175 eatures were dissemination of information to sponsor organizations and hospitals, data collection, an

176 guidance will assist practitioners and their sponsoring organizations in preserving their duty of car

177 decorated capsid is biologically active and sponsors packaging of the viral genome in vitro.

178 1988, Iran has operated the only government-sponsored paid living donor (LD) kidney transplant progr

179 110 trials with results, most were industry-sponsored, parallel-design drug studies.

180 nalysis of the National Institutes of Health-sponsored PAREPET trial (Prediction of Arrhythmic Events

181 The sponsor, participants, and investigators were masked for

182 The study sponsor, participants, and investigators were masked to

183 The study sponsor, participants, and investigators were masked to

184 ubjects in the National Institutes of Health-sponsored Pediatric Heart Network KD pulsed steroid tria

185 atients, study staff, investigators, and all sponsor personnel were masked to treatment assignment.

186 Patients, study investigators, and study sponsor personnel were masked to treatment assignment.

187 Patients, study investigators, and local sponsor personnel were masked to treatment.

188 Sponsor personnel with direct oversight of the conduct a

189 Participants, investigators, sponsor personnel, and clinical research organisation st

190 Participants, sponsor personnel, investigators, and study site personn

191 onto Cancer Therapeutics Evaluation Program-sponsored phase I trials activated between 2000 and 2010

192 To this end, Medicare has sponsored pilot projects to encourage providers to devel

193 The NIDDK-sponsored PIVENS trial (NCT00063622) showed that vitamin

194 ge by Medicare/Medicaid and other government-sponsored plans was similar to the rest of the populatio

195 th the older PMF2 software and the newer EPA-sponsored PMF 3.0 software were employed.

196 As such, participating scientists need to sponsor proactive, solution-focused discussions of its s

197 le disclosure of the presence of COI and for sponsoring professional societies and institutions to ev

198 iences (TESS), a National Science Foundation-sponsored program in which researchers propose survey-ba

199 ge Informatics Platform (PIIP) is an NCI/NIH sponsored project intended for managing, annotating, sha

200 ementia trials, and is progressing in a CAMD-sponsored qualification process for use in registration

201 included all published and unpublished Roche-sponsored randomised placebo-controlled, double-blind tr

202 2 National Heart, Lung, and Blood Institute-sponsored randomized clinical trials in infants with sin

203 a National Heart, Lung, and Blood Institute-sponsored, randomized, double-blind, placebo-controlled,

204 henotypes is a National Institutes of Health-sponsored repository charged to archive, curate and dist

205 s (dbGap) is a National Institutes of Health-sponsored repository charged to archive, curate and dist

206 ians, institutional review boards, and study sponsors represents a simple, practical, and inexpensive

207 earch investigators to ensure that federally sponsored research demonstrates broader societal impact.

208 an overall cost-benefit ratio of government-sponsored research is difficult to estimate because the

209 Current government-sponsored research is some of the best in the world, but

210 cy as it relates to presentation of industry-sponsored research.

211 Finally, journals, funders, sponsors, research ethics committees, regulators, and le

212 e clinical work proceeded, investigators and sponsors responded to specific questions of informed con

213 the new trial designs impact researchers and sponsors responsible for drug development programs, but

214 ions, organization proposals, and government-sponsored reviews.

215 s were assessed by Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Ra

216 up (differences in Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Ra

217 Safety data in the sponsor's clinical development safety database from 10 c

218 Additionally, the sponsor's clinical personnel involved in the study were

219 d of reporting favorable conclusions about a sponsor's proprietary agent in pharmacoeconomic studies.

220 ents, investigators, site personnel, and the sponsor's study team were masked to treatment allocation

221 personnel, laboratory staff, members of the sponsor's study team, and members of the adjudication pa

222 National Institutes of Health (NIH)-sponsored screening centers provide academic researchers

223 olled onto Cancer Therapy Evaluation Program-sponsored single-agent phase I studies over three decade

224 No other terrestrial genus of animals has sponsored so many independent aquatic invasions, and no

225 that is, countries providing stronger state-sponsored social-safety nets for their people, perform b

226 eviewers, and peer review by members of each sponsoring society.

227 eviewers, and peer review by members of each sponsoring society.

228 s involved in assessment of any outcome, and sponsor staff involved in review or analysis of data wer

229 ents, investigators, study monitors, and the sponsor staff were masked to treatment allocation.

230 It is critical that sponsors step forward with funding to conduct these clin

231 The sponsor stopped the trial after a prespecified interim a

232 genetic alterations lags, investigators and sponsors struggle with choosing between ideal clinical t

233 bility criteria in National Cancer Institute-sponsored studies are instructive.

234 Pooled sensitivities favored industry-sponsored studies by 6.2 to 34.0 percentage points.

235 While the conclusions of industry-sponsored studies were indeed more enthusiastic than war

236 ifferences between nonindustry- and industry-sponsored studies, such as selective reporting of outcom

237 e conservative than was seen in non-industry-sponsored studies.

238 lity criteria from National Cancer Institute-sponsored studies.

239 Study site personnel, patients, and the sponsor study personnel were masked to the treatment ass

240 ients, investigators assessing outcomes, and sponsor study personnel were masked to treatment assignm

241 A Clinical Affairs Committee-sponsored study of ID physicians' positive impact on pat

242 The sponsor, study personnel, and participants were masked t

243 ecommendations arising from an NIH-NHLBI/NCI-sponsored symposium held in November 2012, aiming to ide

244 These ATS-sponsored technical standards describe the equipment, pe

245 analysis, non-inferiority was shown and the sponsor terminated the study.

246 ncurrent nonclinical toxicity study, and the sponsor terminated the study.

247 Merely offering to sponsor the experiment similarly endowed the gesturing l

248 l Institute of Environmental Health Sciences sponsored the "Workshop for the Development of a Framewo

249 fectious Diseases Society of America jointly sponsored the development of this guideline for the trea

250 In March 1966, the Ciba Foundation sponsored the first international, interdisciplinary sym

251 l Institute of Environmental Health Sciences sponsored the Workshop on Mitochondria, Energetics, Epig

252 release of confidential interim data by the sponsor, the academic leadership of the study recommende

253 re incomplete, FDA officials have encouraged sponsors to design AA applications on the basis of inter

254 ams; provision of comprehensive PRO plans by sponsors to FDA early in drug development; promotion of

255 n and randomly assigned their insurance-plan sponsors to full prescription coverage (1494 plan sponso

256 e safety needed for human subjects, allowing sponsors to move ahead more quickly with the development

257 voluntarily submitted by chemical companies (sponsors) to the U.S. EPA.

258 sis of a multisite National Cancer Institute-sponsored trial (N9741) was performed comparing outcomes

259 A prospective, open-label, investigator-sponsored trial of intravitreal aflibercept for polypoid

260 This National Institute of Health-sponsored trial will investigate oral iron polysaccharid

261 The trial sponsor, trial monitors, statisticians, investigators, c

262 was less common in industry-sponsored vs NIH-sponsored trials (adjusted odds ratio [OR], 0.11; 95% CI

263 a homogeneous subset of phase II, industrial-sponsored trials for the median calendar time from submi

264 leteness of journal publications of industry-sponsored trials on the effectiveness and harms of rhBMP

265 In contrast to the industry-sponsored trials, depression trials funded by the Nation

266 ated with higher success rates than publicly-sponsored trials, the difference seems to have disappear

267 h on medical devices, problems with industry-sponsored trials, the lack of head-to-head trials of new

268 of all resistance information available from sponsors' trials as a tool to inform the HCV drug develo

269 rial sites participating in study 29X, a CDC-sponsored Tuberculosis Trials Consortium study evaluatin

270 the reported methods by clinical specialty; sponsor type; and the reported use of DMCs, randomizatio

271 Sponsor: University College London (UCL).

272 CTTI recommends that sponsors use a central IRB and discuss trial endpoints w

273 gression, with the Movement Disorder Society-sponsored version of the Unified Parkinson's Disease Rat

274 rted use of DMCs was less common in industry-sponsored vs NIH-sponsored trials (adjusted odds ratio [

275 to treatment assignment; however, the study sponsor was masked to treatment assignment until databas

276 ltrials.gov, Google Scholar, PubMed, Embase, sponsor websites, and direct electronic query of trial c

277 Participants, caregivers, investigators, and sponsor were all blinded to group assignment.

278 cipants, investigators, study staff, and the sponsor were masked to group assignment until all partic

279 ts, investigators, their site personnel, and sponsor were masked to group assignment.

280 Patients, investigators, and the sponsor were masked to PD-L1 expression status.

281 Patients, site study staff, and sponsor were masked to study treatment.

282 Patients, study personnel, and the sponsor were masked to the treatment group assignment.

283 Site investigators, patients, and the sponsor were masked to treatment allocation during the s

284 Patients, investigators, and the study sponsor were masked to treatment assignment.

285 Patients, study personnel, and the sponsor were masked to treatment assignment.

286 tors, patients, data analysts, and the trial sponsor were masked to treatment assignment.

287 Investigators, patients, and the trial sponsor were masked to treatment assignment.

288 Patients, investigators, and the study sponsor were masked to treatment assignment.

289 Patients, investigators, and the trial sponsor were masked to treatment assignments.

290 Patients, physicians, study staff and the sponsor were masked to treatment group allocation.

291 Patients, investigators, and sponsors were blinded to the treatment.

292 Patients, investigators, and trial sponsors were masked to treatment allocation.

293 All participants, investigators, and sponsors were masked to treatment assignments.

294 Investigators, patients, and study sponsors were masked to treatment.

295 epared by personnel from the study's funding sponsor who were not involved with the conduct of the st

296 the National Heart, Lung and Blood Institute-sponsored WISE (Women's Ischemia Syndrome Evaluation), w

297 ors to full prescription coverage (1494 plan sponsors with 2845 patients) or usual prescription cover

298 s) or usual prescription coverage (1486 plan sponsors with 3010 patients) for all statins, beta-block

299 Institute of Allergy and Infectious Diseases-sponsored Working Group and the European Academy of Alle

300 A Water Research Foundation-sponsored workshop gathered experts from across the Unit